Projects per year
Personal profile
Education
- 1993-1995 M.S., Institute of Preventive Medicine, College of Public Health, National Taiwan University
- 1986-1993 M.D., School of Medicine, College of Medicine, National Taiwan University
Experience
- 2012.08- Professor, Department of Psychiatry, Taipei Medical University
- 2009 Chief, Department of Psychiatry, Taipei Medical University-Wan Fang Hospital
- 2009.08-2012.07 Associate Professor, Department of Psychiatry, Taipei Medical University
- 2007.08- Assistant Professor, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 2005.02-2009.07 Assistant Professor, Department of Psychiatry, Taipei Medical University
- 2001 Lecturer, Department of Psychiatry, Taipei Medical University
- 2000 Staff Psychiatrist, Department of Psychiatry, Taipei Medical University-Wan Fang Hospital
- 1999 Staff Psychiatrist, Department of Psychiatry, Shin Kong Wu Ho-Su Memorial Hospital
- 1998 Chief Resident, Taipei City Psychiatric Center
- 1995 Resident, Taipei City Psychiatric Center
Awards
- 2005 Shi-Jin Tsai Memorial Award (Young Investigator Award), Taiwanese Society of Psychiatry
- 2005 Schizophrenia Research Award, Taiwanese Society of Psychiatry
- 2005 Travel Award, Joint Meeting of the 27th Japanese Society of Biological psychiatry and the 35th Japanese Society of Neuropsychopharmacology, Osaka, Japan
- 2007 Ta-You Wu Memorial Award (Young Investigator Award), National Science Council
- 2008 Young Investigator Award, Taipei Medical University
- 2008 Best Research Award, Taipei Medical University
- 2010 Young Scientist Travel Award, The 5th Annual Meeting of Japanese Society of Schizophrenia Research, Fukuoka, Japan
Research Interests
- Psychiatry, Psychopharmacology, Clinical trial
Fingerprint Dive into the research topics where Mong-Liang Lu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 15 Similar Profiles
olanzapine
Medicine & Life Sciences
Schizophrenia
Medicine & Life Sciences
Antipsychotic Agents
Medicine & Life Sciences
Clozapine
Medicine & Life Sciences
Fluvoxamine
Medicine & Life Sciences
Drug Dose Response Relationship
Medicine & Life Sciences
Bipolar Disorder
Medicine & Life Sciences
Psychotic Disorders
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2010 2019
- 10 Finished
長效型metformin對於服用clozapine或olanzapine的思覺失調症患者新陳代謝指標及神經認知功能之劑量效應:隨機、雙盲、安慰劑控制研究(3/3)
8/1/18 → 7/31/19
Project: A - Government Institution › b - Ministry of Science and Technology
長效型metformin對於服用clozapine或olanzapine的思覺失調症患者新陳代謝指標及神經認知功能之劑量效應:隨機、雙盲、安慰劑控制研究(2/3)
8/1/17 → 7/31/18
Project: A - Government Institution › b - Ministry of Science and Technology
Dose Effect of Extended-Release Metformin on Metabolic Parameters and Neurocognitive Function Treated by Clozapine or Olanzapine in Patients with Schizophrenia: a Randomized, Double-Blinded, Placebo-Controlled Trial
8/1/16 → 7/31/17
Project: A - Government Institution › b - Ministry of Science and Technology
Dose Effect of Extended-Release Metformin on Metabolic Parameters and Neurocognitive Function Treated by Clozapine or Olanzapine in Patients with Schizophrenia---A Randomized, Double-Blinded, Placebo-Controlled Trial
8/1/15 → 7/31/16
Project: A - Government Institution › b - Ministry of Science and Technology
Relationships of One-Carbon Cycle Pathways with Psychopathology and Metabolic Abnormalities in Patients with Schizophrenia and Potential Intervention Strategy with 5-Methyltetrahydrofolate and Vitamin B12
8/1/15 → 7/31/16
Project: A - Government Institution › b - Ministry of Science and Technology
Research Output 1997 2019
Antidepressant use and hepatocellular carcinoma in patients with hepatitis C who had received interferon therapy: A population-based cohort study
Chen, V. C. H., Lu, M. L., Yang, Y. H., Weng, J. C. & Chang, C. C., Jun 15 2019, In : Journal of Affective Disorders. 253, p. 147-153 7 p.Research output: Contribution to journal › Article
Hepatitis C
Interferons
Antidepressive Agents
Hepatocellular Carcinoma
Cohort Studies
Exploration of microbiota targets for major depressive disorder and mood related traits
Chung, Y. C. E., Chen, H. C., Chou, H. C. L., Chen, I. M., Lee, M. S., Chuang, L. C., Liu, Y. W., Lu, M. L., Chen, C. H., Wu, C. H., Huang, M. C., Liao, S. C., Ni, Y. H., Lai, M. S., Shih, W. L. & Kuo, P. H., Apr 1 2019, In : Journal of Psychiatric Research. 111, p. 74-82 9 p.Research output: Contribution to journal › Article
Microbiota
Major Depressive Disorder
Depression
Anxiety
Fats
Homocysteine, rather than age of onset, is a better predictor for cognitive function in older adults with bipolar disorder
Chen, P-H., Liu, H-C., Lu, M-L., Chen, C-H., Chang, C-J., Chiu, W-C., Sun, I-W., Liu, S-I., Tsai, S-Y., Chiu, C-C. & Stewart, R., May 21 2019, In : International Journal of Geriatric Psychiatry.Research output: Contribution to journal › Article
Homocysteine
Bipolar Disorder
Age of Onset
Cognition
Blood Vessels
Lamotrigine augmentation in treatment-resistant unipolar depression: A comprehensive meta-analysis of efficacy and safety
Goh, K. K., Chen, C. H., Chiu, Y. H. & Lu, M. L., Jun 1 2019, In : Journal of Psychopharmacology. 33, 6, p. 700-713 14 p.Research output: Contribution to journal › Article
Treatment-Resistant Depressive Disorder
Depressive Disorder
Meta-Analysis
Safety
Depression
New use for old drugs: The protective effect of atypical antipsychotics on hepatocellular carcinoma
Chen, V. C. H., Chan, H. L., Hsu, T. C., Lu, M. L., Lee, Y. C., Lee, Y., Siow, J. Y., McIntyre, R. S., Zhou, A. J., Tzang, B. S. & Lee, C. T. C., 2019, In : International Journal of Cancer.Research output: Contribution to journal › Article
Protective Agents
Antipsychotic Agents
Hepatocellular Carcinoma
Risperidone
Clozapine